SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-300284
Filing Date
2012-07-12
Accepted
2012-07-12 06:59:55
Documents
4
Period of Report
2012-07-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d377857d8k.htm 8-K 38305
2 AMENDMENT TO FOURTH RESTATED AND AMENDED ARTICLES OF INCORPORATION d377857dex31.htm EX-3.1 5768
3 PRESS RELEASE d377857dex991.htm EX-99.1 10832
4 GRAPHIC g377857g43z36.jpg GRAPHIC 6212
  Complete submission text file 0001193125-12-300284.txt   64971
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 12958527
SIC: 2834 Pharmaceutical Preparations